Home / Blood Tests / Lymphocyte subsets (CD69)

Lymphocyte subsets (CD69)

Overview of Lymphocyte Subsets (CD69) Test

The Lymphocyte Subsets (CD69) Test measures CD69+ lymphocytes, an early activation marker found on T-cells, B-cells, and natural killer (NK) cells. CD69 plays a vital role in initiating immune responses and provides important information about immune system activity.

Importance of CD69 Testing

CD69 is one of the earliest indicators of immune activation. Abnormal levels may reflect immune system overactivity, chronic infections, or suppressed immunity, making this test valuable for diagnosing and managing immune-related conditions.

Who Should Consider This Test

Patients with autoimmune disorders such as lupus, rheumatoid arthritis, or multiple sclerosis

Individuals with chronic infections like Epstein-Barr virus (EBV) or HIV

Cancer patients, especially those with leukemia, lymphoma, or tumor-associated immune activity

People experiencing chronic fatigue, fibromyalgia, or persistent inflammation

Transplant recipients to monitor for early signs of rejection or immune suppression

What the Test Can Reveal

Immune Activation: Elevated CD69 levels may indicate an active immune response due to infection or autoimmune disease

Chronic Inflammation: Ongoing immune activity may suggest long-term inflammatory conditions

Immune Suppression: Low CD69 levels could signal immune deficiency or reduced immune function

Clinical Significance

The CD69 test is a critical tool in immunological evaluation. It supports early detection and monitoring of immune-related disorders, enabling timely and effective treatment interventions.

There is an additional £20 phlebotomy fee for every donation.